Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study

J. J. Belch, H. A. Capell, E. D. Cooke, J. D. Kirby, C. S. Lau, R. Madhok, E. Murphy, M. Steinberg

    Research output: Contribution to journalArticlepeer-review

    58 Citations (Scopus)

    Fingerprint Dive into the research topics of 'Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Chemical Compounds